GT Biopharma, Inc. Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

GT Biopharma, Inc. is a clinical-stage biotechnology company focused on developing immuno-oncology therapies and central nervous system product candidates. It is based in Westlake Village, California, and operates with a small team. The company’s immuno-oncology program relies on a proprietary platform that produces multi-specific single-chain antibody constructs, paired with antibody-drug linkers and payloads. Its CNS portfolio centers on reformulations and repurposing of existing therapies that are protected by patent coverage.

In the oncology and CNS spaces, the company advances its pipeline through clinical development. Recent activities include securing an exclusive worldwide license with the University of Minnesota to further develop TriKE technology and advancing a B7-H3-targeted NK cell engager into Phase I testing across solid tumors.

Sign up for free to view info

Company overview Employee directory